| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 17, 2004
From the Divisions of Cardiovascular Diseases (E.B.S.) and General Internal Medicine (G.E.R., M.S.V.-S.), Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City; Center for Research in the Implementation of Innovative Strategies in Practice, Iowa City VA Medical Center, Iowa City, Iowa (G.E.R., M.S.V.-S.); and Division of Cardiothoracic Surgery, Department of Surgery, Oregon Health and Science University, Portland (K.F.W.). * To whom correspondence should be addressed. E-mail: erik-schelbert{at}uiowa.edu.
Background--Most prior studies of racial differences in the delivery of cardiac care have focused on potential differences in treatment by individual physicians and hospitals. However, differential use of hospitals with variable practice patterns might also contribute to variations in care. Methods and Results--We compared the use of bioprosthetic valves (BPVs) in 78 154 black and white Medicare beneficiaries Conclusions--Accounting for differences in hospitals preferentially used by black and white patients had a major impact on estimating racial differences in the use of BPVs in patients undergoing aortic valve replacement. Hospital-level effects explained a larger proportion of the variation in BPV use than race and other patient characteristics alone.
Revised on July 12, 2005
Accepted on July 19, 2005
Treatment Variation in Older Black and White Patients Undergoing Aortic Valve Replacement
Erik B. Schelbert MD*,
65 years of age undergoing aortic valve replacement in 904 US hospitals during 1999 through 2001. Generalized linear mixed models were used to account first for differences in patient characteristics and then for differences in hospitals used by black and white patients. BPV use was lower in black patients relative to white patients after adjustment for patient characteristics (relative risk, 0.93; 95% CI, 0.91 to 0.95; P<0.001). However, black patients were more likely to undergo surgery in hospitals in the lowest quintile of BPV use overall (29% versus 20% of white patients; P<0.001). After hospital-level variability in BPV use was accounted for, the use of BPVs was actually somewhat higher in black patients (relative risk, 1.06; 95% CI, 1.04 to 1.09; P<0.001). Model discrimination as measured by the c statistic was markedly higher after the addition of hospital effects (0.80 versus 0.59 for patient characteristics alone; P<0.001).
This article has been cited by other articles:
![]() |
D. B. Smith, Z. Feng, M. L. Fennell, J. Zinn, and V. Mor Racial Disparities in Access to Long-Term Care: The Illusive Pursuit of Equity Journal of Health Politics Policy and Law, October 1, 2008; 33(5): 861 - 881. [Abstract] [PDF] |
||||
![]() |
E B Schelbert, M S Vaughan-Sarrazin, K F Welke, and G E Rosenthal Valve type and long-term outcomes after aortic valve replacement in older patients Heart, September 1, 2008; 94(9): 1181 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Smith, Z. Feng, M. L. Fennell, J. S. Zinn, and V. Mor Separate And Unequal: Racial Segregation And Disparities In Quality Across U.S. Nursing Homes Health Aff., September 1, 2007; 26(5): 1448 - 1458. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |